Skip to main content
. 2005 Jun 15;5:67. doi: 10.1186/1471-2458-5-67

Table 1.

Sample description (paired sample, N = 1986)

Enterprise 1 N (%) Enterprise 2 N (%) Enterprise 3 N (%) Enterprise 4 N (%) Total N (%)
Sex (***)
 Men 131 (23.9) 206 (42.8) 200 (68.5) 529 (79.7) 1066 (53.7)
 Women 418 (76.1) 275 (47.2) 92 (31.5) 135 (20.3) 920 (46.3)
Education (***)
 Lowest (vocational school or less) 93 (17.0) 160 (33.7) 61 (21.0) 412 (64.1) 726 (37.1)
 Secondary school 35 (6.4) 58 (12.2) 58 (19.9) 121 (18.8) 272 (13.9)
 College 277 (50.5) 174 (36.6) 125 (43.0) 105 (16.3) 681 (34.8)
 Highest (university) 143 (26.1) 83 (17.5) 47 (16.2) 5 (0.8) 278 (14.2)
Age(***)
Mean (standard dev.) 38.9 (8.14) 39.1 (8.75) 39.6 (9.0) 43.2 (7.2) 40.5 (8.4)
 18–34 yrs 162 (29.5) 150 (31.2) 92 (31.5) 69 (11.0) 473 (24.2)
 35–49 yrs 338 (61.6) 279 (58.0) 154 (52.7) 457 (72.7) 1228 (62.9)
 50 and + 49 (8.9) 52 (10.8) 46 (15.8) 103 (16.4) 250 (12.8)
Effort-reward imbalance (*)
 T1 no, T2 no 350 (68.2) 289 (63.2) 170 (60.3) 424 (65.9) 1233 (65.1)
 T1 yes, T2 no 50 (25.5) 46 (10.1) 39 (13.8) 61 (9.5) 196 (10.3)
 T1 no, T2 yes 56 (10.9) 55 (12.0) 27 (9.6) 48 (7.5) 186 (9.8)
 T1 yes, T2 yes 57 (11.1) 67 (14.7) 46 (16.3) 110 (17.1) 280 (14.8)
Overcommitment (high) (**) 164 (30.1) 171 (35.9) 108 (37.2) 272 (41.1) 715 (36.3)
Health (highest quartiles)
 Depression (n.s.) 141 (26.0) 105 (22.0) 59 (20.3) 174 (26.5) 479 (24.3)
 Anxiety (*) 125 (20.3) 127 (26.6) 55 (18.9) 178 (27.1) 485 (24.6)
 Somatisation (**) 149 (27.4) 131 (27.3) 55 (18.9) 194 (29.6) 529 (26.9)
 Chronic fatigue 141 (26.6) 132 (28.3) 74 (26.1) 183 (28.4) 530 (27.5)
 Psychotropic drug consumption 119 (22.8) 91 (19.6) 43 (15.5) 162 (25.6) 415 (21.9)

* p < 0.05, ** p < 0.01, *** p < 0.001